• Ovariectomy induced depression-like behavior in rats.
Introduction
Depression is a significant public health problem due to both its high prevalence and its devastating impact on individuals and society. It was found that ovarian hormones, particularly estrogens, have profound effect on incidence and/or symptomology of Abbreviations: BDNF, brain-derived neurotrophic factor; E2, 17␤-estradiol; MDD, major depressive disorder; OFT, Open field test; OVX, ovariectomy; PFC, prefrontal cortex; TrkB, tropomyosin-related kinase B; TST, Tail suspension test; ERs, estrogen receptors.
depression [1] . Menopausal declines in circulating estrogen levels are associated with increased susceptibility to develop major depressive disorder (MDD) [2] . Rodents have also shown an increase in depression-like behavior during the diestrus phase of the estrous cycle when the levels of estrogens are low [1] . Ovariectomy (OVX), which removes the primary source of estrogens, elicits depression-like behavior in rats [3] .
Several reports have indicated that estrogen replacement therapy can produce antidepressant effects in both clinical and pre-clinical studies [3, 4] . Given that estrogen therapy results in some severe side effects including thrombotic events, breast cancer and dementia [5] , there is obvious interest in developing better and safer therapeutic approaches. Increasing evidence suggests that exercise may play a protective role in mood disorders [6] . Clinical data has shown that physical exercise can reduce depressive symptoms and prevent depression relapse [6] . Animal studies have also suggested exercise amelioration of depression-like behavior [7] . Our previous study has demonstrated that swimming exercise reduces depressive behavior in two rat models of depression [8, 9] . However, there are few studies about the effect of exercise on depression-like behavior caused by estrogen deficiency.
Exercise can modulate some neurotransmitters and neurotrophin expression in clinical and rodent studies [10, 11] . Changed expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), is associated with depression in both humans and animal models [12] . The levels of BDNF and its receptor were decreased in hippocampus of MDD patients [13] . Studies in rodents have indicated that decreased BDNF level in many brain regions is associated with the development of depression-like behavior in OVX rats [3] . Administration of BDNF into the hippocampus of depressive animal model ameliorates the behavioral changes as antidepressant treatment does [14] . In the present study, we therefore investigated the effect of OVX on depression-like behavior and the levels of BDNF and its high-affinity tropomyosin-related kinase B (TrkB) receptor in hippocampus and prefrontal cortex (PFC) in female rats, and then determined whether exercise alleviates the depression-like behavior induced by this paradigm and the expression of BDNF and TrkB. Our study would extend the knowledge of the mechanisms underlying exercise amelioration of depression.
Materials and methods

Animals
A total of 56 adult female Sprague-Dawley rats (Shanghai SLAC Laboratory Animal Co.), weighing 200 ± 20 g, were housed with regular light-dark cycles under controlled temperature (22 ± 2 • C) and humidity (50 ± 10%), and were given standard diet and water ad libitum. All animal protocols were approved by the Ethical Committee of Experimental Animals of Second Military Medical University and Shanghai University of Sport.
Groups, surgical procedure and exercise training
We firstly used 24 rats which were randomly assigned to Sham, OVX and OVX-E 2 groups (n = 8 for each group) to examine the depression-like behavior and the levels of BDNF and TrkB. Sham operation or bilateral OVX was performed under anesthesia with sodium pentobarbital (60 mg/kg, i.p.). After recovery for 1 week, OVX rats were divided into two groups OVX-E 2 and OVX groups. OVX-E 2 rats were subcutaneously administered with E 2 (Sigma-Aldrich, St Louis, MO) (dissolved in 0.1 ml sesame oil) at a dose of 30 g/kg/day for 8 weeks. OVX rats were administered with 0.1 ml sesame oil as placebo for 8 weeks.
To determine the effects of exercise on depression-like behavior, we set up another independent experiment using 32 rats which were randomly assigned to Sham-sedentary (Sham), Sham-exercise (Sham-Ex) groups, OVX-sedentary (OVX) and OVXexercise (OVX-Ex) groups (n = 8 for each group). One week after OVX operation, rats were adapted to the treadmill for 1 week (15 min/day at 15 m/min on a 0% slope) and then gradual increase in running time and speed to 60 min/day at 18 m/min on a 0% slope, 5 days/week for the next 7 weeks (supplement Fig. S1 ).
Behavioral tests
Rats were examined by behavioral tests after 8-week E 2 treatment or exercise. Open field test (OFT) and tail suspension test (TST) were performed as described previously [7, 15] at 14:00 p.m. to 17:00 p.m. In OFT, each rat was placed at the center of the open field (60 × 60 × 60 cm chamber) for 5 min. A video-computerized tracking system was used to record the behavior of the animals. Parameters assessed were total distance (meters), number of crossing squares and immobile episodes. In TST, each rat was suspended by the tail with bands and hung from a mounted hook. The duration of immobility during the total 6 min was measured. Immobile time was defined as a lack of all movement except for whisker movement and respiration.
Blood and tissue sample collection
Rats were decapitated at 12:00 p.m. to 13:00 p.m. Sham rats were sacrificed at the diestrus phase. Trunk blood was collected. Simultaneously, hippocampus and PFC were rapidly separated as described by O'Leary et al. [16] . Serum, hippocampus and PFC were stored at −80 • C until assays.
Determination of E 2 and BDNF
17␤-estradiol (E 2 ) content in serum was assayed using radioimmunoassay kit (Sino-UK Institute of Biological Technology, Beijing, China), and BDNF levels in hippocampus and PFC were determined using ELISA kit (R&D, Minneapolis, USA), following the manufacturer's instructions.
Western blotting analysis
Tissues were homogenized in cold T-Per lysis buffer (Pierce Biotechnology, USA). The protein concentration was determined using a BCA protein Assay Kit (BioTeke, Beijing, China). The samples were quickly sonified in ice bath, boiled 5 min at 95 • C. 50 g protein of each sample was loaded and separated by 10% SDS-PAGE and subsequently transferred to nitrocellulose membranes. The membranes were then incubated with antibodies against TrkB (Santa Cruz, CA) at a dilution 1:500 overnight at 4 • C. After washes, the membrane was incubated with the secondary antibodies of horseradish peroxidase-conjugated antibody. Immunoreactive proteins were detected using the enhanced chemiluminescence Western blotting detection system (Santa Cruz, CA) and visualized using Sygene Bio Image system and analyzed following by GeneSnap and GeneTools software (Synoptics Ltd., UK).
Statistics
Data were presented as mean ± SEM. All data were tested for homogeneity of variance by the Bartlett test at first and then analyzed using one-way or two-way ANOVA followed by Dunnett's or LSD post hoc test. Pearson's correlation analysis was used to examine the relationship between E 2 and BDNF level as well as the parameters of behaviors. All statistics were carried out using SPSS software version 16.0 (SPSS Inc., USA). P < 0.05 was considered significant.
Results
The effects of OVX and E 2 replacement on depression-like behavior
OVX rats showed increased depression-like behavior including decreased total distance (P < 0.01) and number of crossing squares (P < 0.01) in OFT, and increased number of immobile episodes (P < 0.01) in OFT and immobile time (P < 0.01) in TST compared to Sham group. E 2 replacement significantly reduces depression-like behavior in OVX rats (P < 0.01) (Fig. 1A-D) .
The level of E 2 in serum correlated to several behavioral indexes including total distance (R 2 = 0.717, P < 0.01), number of immobile episodes (R 2 = 0.523, P < 0.01) as well as immobility time (R 2 = 0.542, P < 0.01) (Fig. 1F-I ). No significant correlation was found between E 2 level and the behavioral index, the number of crossing squares.
The effects of OVX and E 2 replacement on BDNF level and TrkB expression in hippocampus and PFC
Decreased BDNF and its receptor are involved in depression-like behavior [3] . Some brain areas, such as PFC and hippocampus, have been known to be responsible for depression-like behavior [17] . As shown in Fig. 2 , BDNF level in hippocampus was significantly decreased in OVX rats compared to Sham rats (P < 0.01), which was reversed by E 2 treatment (P < 0.01). Moreover, BDNF level in hippocampus correlated to serum E 2 level (R 2 = 0.304, P < 0.05). BDNF level in PFC was not significantly differed among Sham, OVX and OVX-E 2 groups.
There was no significant difference in TrkB protein expression in hippocampus and PFC among Sham, OVX and OVX-E 2 groups.
Exercise ameliorates depression-like behavior and increases BDNF level in hippocampus of OVX rats
Exercise ameliorated depression-like behavior in OVX rats, including increasing total distance (P < 0.01) and number of crossing squares (P < 0.01) and decreasing number of immobile episodes (P < 0.01) and immobile time in TST (P < 0.05) (Fig. 3A-D) . Exercise did not affect the above behaviors in Sham rats.
Exercise could increase serum E 2 level in OVX rats (P < 0.05) (Fig. 3E ). E 2 level correlated to total distance (R 2 = 0.500, P < 0.05) and the number of immobile episodes (R 2 = 0.273, P < 0.05), but did not correlate to the number of crossing squares and immobility time (Fig. 3F-I ).
Exercise significantly increased BDNF level in hippocampus but not in PFC in both Sham (P < 0.05) and OVX rats (P < 0.01) (Fig. 4A  and B) . BDNF level in hippocampus did not correlate to E 2 level in OVX rats with or without exercise (Fig. 4C) .
There was no significant difference in TrkB protein expression in hippocampus and PFC among the experimental groups ( Fig. 4D  and E) .
Discussion
The present study has demonstrated that OVX induced depression-like behavior by showing decreased total distance and number of crossing squares, as well as increased number of immobile episodes in OFT and immobile time in TST in rats. Both E 2 treatment and exercise ameliorated depression-like behavior in OVX rats. OVX resulted in a decrease in BDNF level in hippocampus but not in PFC, which can be restored by E 2 -replacement as well as exercise.
OVX rats exhibit depression-like behavior and estrogen treatment can decrease depression-like behavior or facilitate antidepressant action [18] . The present study showed E 2 treatment ameliorated depression-like behavior including a decrease in locomotor activity and behavioral despair in OVX and serum E 2 level correlated to some parameters of depression-like behavior, confirming the antidepressant effect of E 2 .
Infusion of BDNF into brain or hippocampus has antidepressantlike effects [14] . Many antidepressant drugs exert their effects through modulation of BDNF expression in the hippocampus in humans and animal models [12] . The present study showed that OVX decreased BDNF expression in hippocampus while caused depression-like behavior, which was restored by E 2 replacement. E 2 level positively correlated to BDNF level in hippocampus. These data are consistent with previous studies that estrogen replacement increases BDNF expression in many brain regions including hippocampus in OVX rats [3] . Activation of TrkB has been implicated to play a role in antidepressant action [19] . We found that OVX and E 2 replacement did not affected TrkB protein expression in hippocampus and PFC. However, whether E 2 affect the level of phosphorylated TrkB remains to be elucidated. Several brain regions including the PFC, amygdala, and hippocampus have been implicated in mood disorders [17] . Hippocampus has been considered as an important component of the limbic system and the target of estrogens [1, 20] . It has been shown that E 2 is concentrated in hippocampus after administration of E 2 into female rats [1, 21] . Our data that OVX and E 2 replacement caused changed BDNF level in hippocampus support that hippocampus is a putative focal area for estrogens. In the present study, it is hard to explain why estrogen has no effect on BDNF in PFC. Classically estrogen binding to estrogen receptors (ERs) enhances the ability of receptors to bind to estrogen response elements (EREs) in the promoter many, though not all, estrogen-response genes [22] . Once at the promoter, estrogen-bound ER, interacts with coregulator proteins to form a multiprotein complex that modulates the expression of target genes [23] . It is known that the differences in subtype of ERs and the coregulator proteins are responsible for the tissue-specific effects of estrogen. Both of ER␣ and ER␤ have been identified in hippocampus and PFC [1, 24] . However, the coregulators responsible for estrogen actions in hippocampus and PFC remain unknown. Moreover, we could not exclude other possibilities for the discriminative effect of estrogen on BDNF in different brain regions. Such as, duration of estrogen treatment in the present study might be not enough to cause significant influence on BDNF in PFC.
So far, few studies have focused on the effect of exercise on estrogen deficiency-induced depression. We showed that exercise ameliorated depression-like behavior including a decrease in locomotor activity and behavioral despair in OVX rats, indicating that exercise is effective as antidepressant treatment does. However, the mechanisms underlying exercise improve depression remain largely unknown. Exercise can increase estrogen level in the peripheral circulation of OVX rats [25] . Although we demonstrated that exercise increased serum E 2 level, the serum E 2 level only correlated to some behavior parameters such as locomotor activity in these rats. Thus, it suggests that serum E 2 level may be associated with certain aspects of depression-like behavior. And in addition to increasing serum E 2 level, other mechanisms might also be involved in exercise amelioration of depression. Meeusen [26] has demonstrated that exercise promotes the secretion of neurotransmitters including 5-HT, which may partly explain the beneficial effect of exercise on depressive symptoms.
Exercise can enhance hippocampal function by increasing the production of BDNF, which is associated with antidepressive effect of exercise [27] . Consistently, the present study showed that exercise resulted in a significant increase in BDNF level in hippocampus. However, we also found that increased E 2 level did not correlate to BDNF level in hippocampus in the rats with exercise. It may suggest that other factors might also be involved in the stimulatory effect of exercise on BDNF. For example, it has been shown that exercise can induce hippocampal BDNF by increasing the expression of fibronectin type III domain-containing protein 5 [28] .
In conclusion, OVX induces depression-like behavior and downregulates BDNF level in hippocampus. Estrogen replacement and exercise ameliorate depression-like behavior and reverse BDNF level in hippocampus. Exercise amelioration of depression is partly due to increasing E 2 level in circulation.
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